Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Regulus Therapeutics Inc. (RGLS)

2.3200
+0.3100
+(15.42%)
At close: April 22 at 4:00:01 PM EDT
2.3400
+0.02
+(0.86%)
After hours: April 22 at 6:09:42 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
50,040
50,040
31,109
28,239
27,816
Operating Income
-50,040
-50,040
-31,109
-28,239
-27,816
Net Non Operating Interest Income Expense
3,683
3,683
1,073
-83
9
Pretax Income
-46,357
-46,357
-30,036
-28,322
-27,807
Tax Provision
1
1
1
1
1
Net Income Common Stockholders
-46,358
-46,358
-30,037
-28,323
-27,808
Diluted NI Available to Com Stockholders
-46,358
-46,358
-30,037
-28,323
-27,808
Basic EPS
-1.02
-0.82
-1.58
-1.86
-3.20
Diluted EPS
-1.02
-0.82
-1.58
-1.86
-3.20
Basic Average Shares
45,013.4310
56,346.0330
18,960.4010
15,259.9580
8,570.4530
Diluted Average Shares
45,013.4310
56,346.0330
18,960.4010
15,259.9580
8,570.4530
Total Operating Income as Reported
-50,040
-50,040
-31,109
-28,239
-27,816
Total Expenses
50,040
50,040
31,109
28,239
27,816
Net Income from Continuing & Discontinued Operation
-46,358
-46,358
-30,037
-28,323
-27,808
Normalized Income
-46,358
-46,358
-30,037
-28,323
-27,808
Interest Income
3,841
3,841
1,677
605
864
Interest Expense
158
158
604
688
855
Net Interest Income
3,683
3,683
1,073
-83
9
EBIT
-46,199
-46,199
-29,432
-27,634
-26,952
EBITDA
-45,852
-45,852
-29,205
-27,512
-26,493
Reconciled Depreciation
347
347
227
122
459
Net Income from Continuing Operation Net Minority Interest
-46,358
-46,358
-30,037
-28,323
-27,808
Normalized EBITDA
-45,852
-45,852
-29,205
-27,512
-26,493
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
12/31/2021 - 10/9/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HURA TuHURA Biosciences, Inc.
4.0800
-2.86%
 
VTYX Ventyx Biosciences, Inc.
1.1800
+4.42%
 
GOSS Gossamer Bio, Inc.
0.8274
+1.77%
 
TVTX Travere Therapeutics, Inc.
15.88
+5.10%
 
TARA Protara Therapeutics, Inc.
3.9400
+2.34%
 
THTX Theratechnologies Inc.
2.7300
+7.06%
 
DAWN Day One Biopharmaceuticals, Inc.
7.33
+2.66%
 
NKTX Nkarta, Inc.
2.2200
+20.00%
 
MLTX MoonLake Immunotherapeutics
39.45
-1.37%
 
DYN Dyne Therapeutics, Inc.
9.91
+6.22%